Related Experiment Video
Updated: Jul 18, 2026

Simultaneous Electrocardiography Recording and Invasive Blood Pressure Measurement in Rats
Published on: January 31, 2019
Systolic hypertension
1SUNY Upstate Medical University, Syracuse Preventive Cardiology Center, Syracuse, NY, USA.
Insights
Managing systolic hypertension is crucial for reducing cardiovascular mortality and stroke in older adults. Combination therapy, particularly with calcium-channel blockers and ACE inhibitors, shows promise for effective blood pressure control and improved tolerability.
Area of Science:
- Cardiology
- Geriatrics
- Pharmacology
Background:
- Hypertension affects one-third of adults, with systolic hypertension being a significant concern in older populations.
- Despite proven benefits, controlling systolic blood pressure remains a challenge in clinical practice.
- Elevated systolic blood pressure is a major cardiovascular risk factor, contributing to mortality and stroke.
Purpose of the Study:
- To review systolic blood pressure as a cardiovascular risk factor.
- To discuss effective management strategies for elevated systolic blood pressure.
- To emphasize the role of combination therapy in managing hypertension.
Main Methods:
- Review of large-scale clinical trials and scientific literature.
- Analysis of systolic blood pressure as a cardiovascular risk factor.
- Evaluation of combination therapy, specifically calcium-channel blockers and ACE inhibitors.
Main Results:
- Treatment of isolated systolic and systolic/diastolic hypertension reduces mortality and stroke rates in older adults.
- Combination therapy with calcium-channel blockers and ACE inhibitors demonstrates blood pressure-lowering efficacy.
- This combination may offer additional benefits in tolerability and cognitive function.
Conclusions:
- Effective management of elevated systolic blood pressure is essential for cardiovascular health in older adults.
- Combination therapy, particularly with calcium-channel blockers and ACE inhibitors, is a key strategy for improving blood pressure control.
- Metabolically neutral agents in combination may enhance patient outcomes beyond blood pressure reduction.
Abstract:
Approximately one-third of the adult population has hypertension. Large-scale clinical trials have convincingly demonstrated that the treatment of isolated systolic and systolic/diastolic hypertension reduces rates of total mortality, cardiovascular mortality, and stroke in older adults, yet control of systolic hypertension remains poor. This article reviews systolic blood pressure as a cardiovascular risk factor and discusses effective management of elevated systolic blood pressure. The role of combination therapy is emphasized, focusing on the combination of a calcium-channel blocker and an angiotensin-converting enzyme inhibitor. In addition to blood pressure-lowering efficacy, the combination of these two classes of metabolically neutral agents may offer benefit in terms of tolerability and cognitive function.
Related Concept Videos
Hypertension I: Introduction
Disorders of the Autonomic Nervous System
Raynaud's disease, also known as Raynaud's phenomenon, is a...
Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension II: Pathophysiology
Measurement of Blood Pressure
Alterations in Blood Pressure
Hypertension (High blood pressure)
Hypertension occurs when blood pressure readings consistently exceed the normal range. It is diagnosed when systolic blood pressure (the top number, indicating pressure while the heart beats)...